Loredana Marcu

Prof Loredana Marcu

School of Allied Health and Human Performance

College of Health

Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.


Dr. Loredana G. Marcu is currently a Professor of Medical Physics at the University of Oradea, Romania and Adjunct Professor at School of Health Sciences, University of South Australia. She received her PhD in Medical Physics from the University of Adelaide, and her Masters degree in Applied Physics from the West University of Timisoara, Romania. During her Australian experience she has coordinated the LDR brachytherapy programme at the Royal Adelaide Hospital. She was also a TEAP (Training Education and Accreditation Program) preceptor supervising and coordinating the medical physics training and education of the junior physicists in South Australia.
Her 20 years teaching experience at both Australian and Romanian universities has materialised in 14 books/book chapters published on physics, radiobiology and teaching methodologies, respectively, with other two books on Medical Physics being currently in press. She has written 5 textbooks and university lab guides and has over 140 publications and conference presentations worldwide. As a postgraduate coordinator, she has co-supervised 3 PhD students and supervised 21 MSc students. 
Dr. Marcu is involved in several professional activities being member of the Women in Medical Physics and Biomedical Engineering Task Group within IUPESM, national representative for Romania in EFOMP and IOMP and the vice-president of the Romanian College of Medical Physicists. She has been member/chair of the organising/scientific committee of 10 national and international conferences. Dr. Marcu has been awarded the title “Eminent Scientist of the year 2004” by the International Council for Research and she is the recipient of the “Boyce Worthley award 2006” given by the Australasian College of Physical Scientists and Engineers in Medicine for her achievements in the areas of radiobiology and medical physics.

Date Position Institution name
2012 - ongoing Professor University of Oradea

Date Institution name Country Title
2000 - 2005 University of Adelaide Australia PhD

Year Citation
2026 Catona, G. M., & Marcu, L. G. (2026). The role of cone beam CT in personalization of bladder cancer radiotherapy. Radiological Physics and Technology, 19(1), 176-189.
DOI
2026 Coc, F. L., & Marcu, L. G. (2026). Treatment planning parameters in intensity modulated radiotherapy for prostate cancer and their dosimetric impact: a study using Monaco TPS. Radiation and Environmental Biophysics, 65(1), 473-489.
DOI
2026 Puzantian, B., Myssayev, A., Applegate, K., Jeffries, C., Umar, M. S., Waltenburg, H., . . . Marcu, L. G. (2026). An international survey of radiological protection in medical research programmes involving human volunteers. Physica Medica, 145, 8 pages.
DOI
2026 Costin, I. C., Marcu, D. C., & Marcu, L. G. (2026). AI-Based Dose Compliance of Secondary Organs at Risk in Head and Neck Cancer Radiotherapy. Diagnostics, 16(11), 1748-1-1748-18.
DOI
2026 Coc, F. L., & Marcu, L. G. (2026). Implementation-oriented evaluation of IMRT and VMAT configurations for prostate radiotherapy: a decision-support framework for technique selection. Health and Technology, 1-12.
DOI
2026 Dickson, J. C., Boman, E., Amos, R. A., Marcu, L., & Torresin, A. (2026). The history and contributions of the EFOMP science committee: an overview. Physica Medica, 147, 3 pages.
DOI
2026 Zahu, R., Farcasanu, A., Eva, A., Domokos, R., Trandafir, D., Dordai, D., . . . Kacso, G. (2026). Anatomy-based definition of posterior neck in head and neck VMAT plan optimization as potential new organ at risk. Medical Dosimetry, 51(2), 235-238.
DOI Scopus1
2026 Coc, F. L., & Marcu, L. G. (2026). Qualitative and dosimetric evaluation of AI-generated contours for conventional and under-reported organs at risk in prostate cancer radiotherapy. Physica Medica, 148, 13 pages.
DOI
2026 Marcu, L. G., Clement, C., Friedl, A., Harbron, R., Harbron, R., Rühm, W., . . . Woloschak, G. (2026). The declaration of Adelaide white paper: guidelines for author responsibility in peer review<sup/>.. Journal of radiological protection : official journal of the Society for Radiological Protection, 46(3), 030202.
DOI
2026 Marcu, L. G., Clement, C., Friedl, A., Harbron, R., Rühm, W., Stoeva, M., . . . Woloschak, G. (2026). The declaration of Adelaide white paper: guidelines for author responsibility in peer review.. Radiation and environmental biophysics.
DOI
2026 Marcu, L. G., Clement, C., Friedl, A., Harbron, R., Rühm, W., Stoeva, M., . . . Woloschak, G. (2026). The declaration of Adelaide white paper: guidelines for author responsibility in peer review.. Physical and engineering sciences in medicine.
DOI
2025 Bezak, E., Sharrad, K. J., Marcu, L. G., Stoeva, M., Lhotska, L., Barabino, G., . . . Frize, M. (2025). A gender breakdown of unexpected benefits generated by work from home in STEM fields − a qualitative analysis of the WiMPBME Task Group survey. Physica Medica, 130, 1-5.
DOI
2025 Marcu, L. G., Marcu, D. C., Costin, I. C., Zahu, R., & Straciuc, O. (2025). From immunohistochemistry to machine learning-based patient stratification by tumour proliferation characteristics in head and neck cancer. Critical Reviews in Oncology Hematology, 216, 10 pages.
DOI Scopus1 WoS1
2025 Marcu, L. G., & Marcu, D. C. (2025). Examining the role of AI in cancer imaging through the lens of clinical studies. Health And Technology, online(6), 1-10.
DOI Scopus1 WoS2
2025 Costin, I. C., Marcu, L. G., Marcu, D. C., Zahu, R., & Straciuc, O. (2025). Is the use of machine learning in head and neck cancer radiotherapy supported by clinical trials?. Physica Medica, 136(105036), 105036-1-105036-17.
DOI Scopus1 WoS1
2025 Coc, F. L., & Marcu, L. G. (2025). From CBCT to MR-Linac in image-guided prostate cancer radiotherapy towards treatment personalization. Current Oncology, 32(6, article no. 291), 1-20.
DOI Scopus2 WoS2 Europe PMC1
2025 Gazsi, I., & Marcu, L. G. (2025). The impact of pre-treatment image guidance on tumor and normal tissue dosimetry during VMAT for cervical cancer. Romanian Journal of Physics, 70(1-2, article no. 701), 1-17.
DOI
2025 Gazsi, I., & Marcu, L. G. (2025). Systematic review of SBRT boost for cervical cancer patients who cannot benefit from brachytherapy. Current Oncology, 32(3, article no. 170), 1-19.
DOI Scopus5 WoS6 Europe PMC2
2025 Gazsi, I., & Marcu, L. G. (2025). Comparative dosimetric assessment of combined treatment modalities in cervical cancer radiotherapy for optimal organ protection. Radiation And Environmental Biophysics, 64(2), 291-302.
DOI
2025 Catona, G. M., & Marcu, L. G. (2025). Qualitative and quantitative evaluation of the role of CBCT in rectal cancer radiotherapy. Radiologia Medica, 130(2), 150-160.
DOI Scopus6 WoS6 Europe PMC5
2025 Costin, I. C., & Marcu, L. G. (2025). Impact of immobilization system angle, body mass index and breast size on breast radiotherapy accuracy using EPID-only setup. Heliyon, 11(3), 1-15.
DOI Scopus2 WoS1 Europe PMC1
2024 Costin, I. C., & Marcu, L. G. (2024). Patient and treatment-related factors that influence dose to heart and heart substructures in left-sided breast cancer radiotherapy. Physica Medica, 128(104851), 104851-1-104851-20.
DOI Scopus2 WoS3 Europe PMC2
2024 Costin, I. C., Cinezan, C., & Marcu, L. G. (2024). Cardio-oncology concerns in radiotherapy: Heart and cardiac substructure toxicities from modern delivery techniques. Critical Reviews in Oncology/Hematology, 204(104538), 104538-1-104538-19.
DOI Scopus11 WoS11 Europe PMC6
2024 Costin, I. C., & Marcu, L. G. (2024). Correlations between patient-specific parameters and dosimetric indices for personalized breast cancer radiotherapy. Scientific Reports, 14(1, article no. 26141), 1-19.
DOI Scopus1
2024 Marcu, L. G., & Marcu, D. C. (2024). Pharmacogenomics and Big Data in medical oncology: developments and challenges. Therapeutic Advances in Medical Oncology, 16, 1-18.
DOI Scopus7 WoS8 Europe PMC3
2024 Ghemiș, D. M., & Marcu, L. G. (2024). RTOG 0915-compliant patient specific QA for lung stereotactic body radiotherapy using the new PTW 1600SRS detector array. Physica Medica, 127(104822), 104822-1-104822-8.
DOI
2024 Buciuman, N., Dasu, A., & Marcu, L. G. (2024). Dosimetric evaluation of intensity modulated photon versus proton reirradiation of head and neck cancer. Physica Medica, 123, 1-10.
DOI Scopus1 WoS1
2024 Costin, I. C., & Marcu, L. G. (2024). Affinity of PET-MRI tracers for hypoxic cells in breast cancer: a systematic review. Cells, 13(12, article no. 1048), 1-14.
DOI Scopus5 WoS4 Europe PMC3
2024 Costin, I. C., & Marcu, L. G. (2024). Evaluation of heart substructures as a function of dose and radiation-induced toxicities in left-sided breast cancer radiotherapy. European Journal of Cancer Care, 2024(1294250), 1-12.
DOI Scopus6 WoS6
2024 Marcu, L. G. (2024). Circadian rhythm-based cancer therapy in randomised clinical trials. Expert Review of Anticancer Therapy, 24(1-2), 29-39.
DOI Scopus13 WoS9 Europe PMC7
2024 Abbott, N. L., Chauvie, S., Marcu, L., DeJean, C., Melidis, C., Wientjes, R., . . . Hansen, C. R. (2024). The role of medical physics experts in clinical trials: a guideline from the European Federation of Organisations for Medical Physics. Physica Medica, 126(104821), 1-16.
DOI Scopus2 WoS2 Europe PMC2
2023 Marcu, L. G., Moghaddasi, L., & Bezak, E. (2023). Cannot target what cannot be seen: molecular imaging of cancer stem cells. International Journal of Molecular Sciences, 24(2, article no. 1524), 1-17.
DOI Scopus7 WoS6 Europe PMC6
2023 Bezak, E., Borrás, C., Hasford, F., Karmaker, N., Keyser, A., Stoeva, M., . . . Marcu, L. G. (2023). Science diplomacy in medical physics - an international perspective. Health and Technology, 13(3), 495-503.
DOI Scopus7 WoS7 Europe PMC5
2023 Marcu, L. G., Dell'Oro, M., & Bezak, E. (2023). Opportunities in cancer therapies: deciphering the role of cancer stem cells in tumour repopulation. International Journal of Molecular Sciences, 24(24), 1-16.
DOI Scopus6 WoS6 Europe PMC5
2023 Gazsi, I., & Marcu, L. G. (2023). Dosimetric evaluation of the benefits of intensity modulated techniques in cervical cancer radiotherapy. Romanian Journal of Physics, 68(7-8), 1-13.
Scopus2 WoS2
2023 Buciuman, N., & Marcu, L. G. (2023). Dosimetric and clinical aspects of head and neck cancer reirradiation with intensity modulated radiotherapy techniques over the last decade. Physica Medica-European Journal Of Medical Physics, 112(102650), 1-9.
DOI Scopus2 WoS2 Europe PMC1
2023 Ghemis, D. M., Marcu, L. G., Virag, V., & Virag, A. (2023). Dosimetric characteristics of 6MV flattening filter free and flattened beams among beam-matched linacs: a three-institutional study. Radiation Oncology, 18(1, article no. 126), 1-11.
DOI Scopus10 WoS9 Europe PMC5
2023 Marcu, D. C., Grava, C., & Marcu, L. G. (2023). Current role of delta radiomics in head and neck oncology. International Journal of Molecular Sciences, 24(3), 1-11.
DOI Scopus23 WoS22 Europe PMC22
2023 Ghemiș, D. M., & Marcu, L. G. (2023). Dosimetric parameters in hypofractionated stereotactic radiotherapy for brain metastases: do flattening filter-free beams bring benefits? A preliminary study. Cancers, 15(3), 1-12.
DOI Scopus2 WoS2 Europe PMC1
2023 Ebert, A., Short, M., Pule, L., Marcu, L., & Buckely, E. (2023). Variations in patterns of care of rectal cancer patients in South Australia according to sociodemographic characteristics: a registry study. European Journal of Cancer Care, 2023(7974059), 1-7.
DOI
2023 Caruana, C. J., Amos, R. A., Burgos, D., Heukelom, S., Jeremic, M. Z., Julkunen, P., . . . Pesznyak, C. (2023). EFOMP policy statement 18: medical physics education for the non-physics healthcare professions. Physica Medica, 111(102602), 1-4.
DOI Scopus2 WoS1 Europe PMC1
2023 Byrne, B., Marcu, L., Mazzoni, L. N., Caruana, C. J., Barry, A., Martin, G. M., . . . Gilligan, P. (2023). EFOMP Malaga Declaration 2023: An updated vision on Medical Physics in Europe. Physica Medica-European Journal Of Medical Physics, 111(102620), 1-3.
DOI Scopus16 WoS13 Europe PMC10
2022 Bezak, E., Carson Chahhoud, K. V., Marcu, L. G., Stoeva, M., Lhotska, L., Barabino, G. A., . . . Frize, M. (2022). The biggest challenges resulting from the COVID-19 pandemic on gender-related work from home in biomedical fields: world-wide qualitative survey analysis. International Journal of Environmental Research and Public Health, 19(5), 1-16.
DOI Scopus26 WoS18 Europe PMC12
2022 Moghaddasi, L., Reid, P., Bezak, E., & Marcu, L. G. (2022). Radiobiological and treatment-related aspects of spatially fractionated radiotherapy. International Journal of Molecular Sciences, 23(6, article no. 3366), 1-21.
DOI Scopus48 WoS46 Europe PMC36
2022 Frize, M., Tsapaki, V., Lhotska, L., da Silva, A. M. M., Ibrahim, F., Bezak, E., . . . Marcu, L. G. (2022). Women in medical physics and biomedical engineering: past, present and future. Health and Technology, 12(3), 655-662.
DOI Scopus3 WoS2 Europe PMC2
2022 Marcu, L. G., Bezak, E., & Sykes, P. J. (2022). Radiation research journals need to stipulate minimal dosimetry requirements for publishing research using x-radiation exposures. Radiation Research, 198(2), 204-206.
DOI Scopus6 WoS5 Europe PMC5
2022 Irazola, L., Marcu, L. G., & Koutsouveli, E. (2022). Early career medical physicists' section at the 4th European Congress of Medical Physics. Physica medica, 103, 74-75.
DOI Scopus3 WoS3 Europe PMC2
2022 Marcu, L. G. (2022). Developments on tumour site-specific chrono-oncology towards personalised treatment. Critical Reviews in Oncology / Hematology, 179(103803), 1-10.
DOI Scopus9 WoS6 Europe PMC3
2022 Costin, I. C., & Marcu, L. G. (2022). Factors impacting on patient setup analysis and error management during breast cancer radiotherapy. Critical Reviews in Oncology/Hematology, 178(103798), 1-13.
DOI Scopus19 WoS19 Europe PMC13
2022 Marcu, L. G., Abbott, N. L., Appelt, A., Chauvie, S., Gasnier, A., Hansen, C. R., . . . O'Doherty, J. (2022). The role of medical physicists in clinical trials across Europe. Physica Medica, 100, 31-38.
DOI Scopus2 WoS3 Europe PMC2
2022 Buciuman, N., & Marcu, L. G. (2022). Adaptive radiotherapy in head and neck cancer using volumetric modulated arc therapy. Journal of Personalized Medicine, 12(5), 1-13.
DOI Scopus13 WoS13 Europe PMC9
2022 Buciuman, N., & Marcu, L. G. (2022). Is there a dosimetric advantage of volumetric modulated arc therapy over intensity modulated radiotherapy in head and neck cancer?. European Archives of Oto-Rhino-Laryngology, 279(11), 5311-5321.
DOI Scopus7 WoS4 Europe PMC2
2022 Marcu, L. G., Caruana, C. J., Lopez Medina, A., Mazzoni, L. N., Polycarpou, I., Manetou, A., & Koutsouveli, E. (2022). Early career medical physicist groups in Europe: an EFOMP survey. Physica Medica, 95, 89-93.
DOI Scopus9 WoS8 Europe PMC4
2022 Marcu, L. G. (2022). Gender and sex-related differences in normal tissue effects induced by platinum compounds. Pharmaceuticals, 15(2, article no. 255), 1-14.
DOI Scopus23 WoS20 Europe PMC18
2021 Marcu, L. G., Bezak, E., Peukert, D. D., & Wilson, P. (2021). Translational Research in FLASH Radiotherapy—From Radiobiological Mechanisms to In Vivo Results. Biomedicines, 9(2), 1-15.
DOI Scopus37 WoS32 Europe PMC25
2021 Marcu, L. G., Chau, M., & Bezak, E. (2021). How much is too much? Systematic review of cumulative doses from radiological imaging and the risk of cancer in children and young adults.. Critical reviews in oncology/hematology, 160(103292), 103292.
DOI Scopus34 WoS30 Europe PMC24
2021 Frize, M., Lhotska, L., Marcu, L. G., Stoeva, M., Barabino, G., Ibrahim, F., . . . Bezak, E. (2021). The impact of COVID-19 pandemic on gender-related work from home in STEM fields-Report of the WiMPBME Task Group. Gender, Work and Organization, 28(S2), 378-396.
DOI Scopus32 WoS27 Europe PMC15
2021 Li, Y., Marcu, L. G., Hull, A., & Bezak, E. (2021). Radioimmunotherapy of glioblastoma multiforme - Current status and future prospects. Critical Reviews in Oncology/Hematology, 163(103395), 1-18.
DOI Scopus20 WoS17 Europe PMC14
2021 Reid, P., Staudacher, A. H., Marcu, L. G., Olver, I., Moghaddasi, L., Brown, M. P., & Bezak, E. (2021). Characteristic differences in radiation-induced DNA damage response in human papillomavirus-negative and human papillomavirus-positive head and neck cancers with accumulation of fractional radiation dose. Head and Neck, 43(10), 3086-3096.
DOI Scopus1 WoS1 Europe PMC1
2021 Marcu, L. G., & Marcu, D. C. (2021). Current omics trends in personalised head and neck cancer chemoradiotherapy. Journal of Personalized Medicine, 11(11, article no. 1094), 1-13.
DOI Scopus13 WoS12 Europe PMC14
2021 Buciuman, N., & Marcu, L. G. (2021). Dosimetric justification for the use of volumetric modulated arc therapy in head and neck cancer—a systematic review of the literature. Laryngoscope Investigative Otolaryngology, 6(5), 999-1007.
DOI Scopus25 WoS22 Europe PMC18
2021 Ghemiş, D. M., & Marcu, L. G. (2021). Progress and prospects of flattening filter free beam technology in radiosurgery and stereotactic body radiotherapy. Critical Reviews in Oncology/Hematology, 163(103396), 1-10.
DOI Scopus16 WoS16 Europe PMC8
2021 Casares Magaz, O., Marcu, L. G., Prezado, Y., Koutsouveli, E., & Brambilla, M. (2021). EFOMP survey results on national radiotherapy dosimetry audits. Physica Medica, 84, 10-14.
DOI Scopus10 WoS10 Europe PMC5
2021 Bodale, M., & Marcu, L. G. (2021). 140 years of medical physics in Romania. Physica Medica, 82, 46-53.
DOI Scopus2 WoS1
2021 Marcu, L. G., & Marcu, D. (2021). Points of view on artificial intelligence in medical imaging-one good, one bad, one fuzzy. Health and Technology, 11(1), 17-22.
DOI Scopus13 WoS10
2021 Marcu, L. (2021). COVID-19 vaccination rates of medical physicists throughout Europe. Physica Medica, 28, 341-342.
DOI
2020 Al Darwish, R., Marcu, L., & Bezak, E. (2020). Overview of current applications of the Timepix detector in spectroscopy, radiation and medical physics. Applied Spectroscopy Reviews, 55(3), 243-261.
DOI Scopus8 WoS10
2020 De Courcy, L., Bezak, E., & Marcu, L. G. (2020). Gender-dependent radiotherapy: The next step in personalised medicine?. Critical Reviews in Oncology/Hematology, 147(102881), 102881-1-102881-8.
DOI Scopus67 WoS62 Europe PMC53
2020 Reid, P., Staudacher, A. H., Marcu, L. G., Olver, I., Moghaddasi, L., Brown, M. P., & Bezak, E. (2020). Influence of the human papillomavirus on the radio-responsiveness of cancer stem cells in head and neck cancers. Scientific Reports, 10(1), 1-8.
DOI Scopus12 WoS13 Europe PMC11
2020 Wong, H. Y., Marcu, L. G., Bezak, E., & Parange, N. A. (2020). Review of health economics of point-of-care testing worldwide and its efficacy of implementation in the primary health care setting in remote Australia. Risk Management and Healthcare Policy, 13, 379-386.
DOI Scopus16 WoS12 Europe PMC14
2020 Reid, P., Staudacher, A. H., Marcu, L. G., Olver, I., Moghaddasi, L., Brown, M. P., . . . Bezak, E. (2020). Intrinsic Radiosensitivity Is Not the Determining Factor in Treatment Response Differences between HPV Negative and HPV Positive Head and Neck Cancers.. Cells, 9(8), 1-14.
DOI Scopus9 WoS9 Europe PMC8
2020 Marcu, L. G. (2020). Imaging biomarkers of tumour proliferation and invasion for personalised lung cancer therapy. Journal of Personalized Medicine, 10(4), 1-17.
DOI Scopus11 WoS8 Europe PMC6
2020 Marcu, L. G. (2020). Cancer stem cells as therapeutic targets of pancreatic cancer. Fundamental and Clinical Pharmacology, 34(2), 202-212.
DOI Scopus8 WoS6 Europe PMC6
2020 Dinu, A., Flonta, T., & Marcu, L. G. (2020). The impact of breast irradiation using thermoplastic mask on treatment delivery and acute effects. Romanian Reports in Physics, 72(2), 1-12.
Scopus2 WoS2
2020 Marcu, L. G. (2020). The ever-changing role of medical physicists in the era of personalized medicine. Journal of Medical Physics, 45(4), 197-198.
DOI Scopus3 Europe PMC4
2020 Dinu, A., Flonta, T., & Marcu, L. G. (2020). The impact of breast irradiation using thermoplastic mask on treatment delivery and acute effects. Romanian Reports in Physics, 72(2, article no. 603), 1-11.
2019 Huynh, M., Marcu, L. G., Giles, E., Short, M., Matthews, D., & Bezak, E. (2019). Are further studies needed to justify the use of proton therapy for paediatric cancers of the central nervous system? A review of current evidence. Radiotherapy and Oncology, 133, 140-148.
DOI Scopus17 WoS17 Europe PMC15
2019 Reid, P., Marcu, L. G., Olver, I., Moghaddasi, L., Staudacher, A. H., & Bezak, E. (2019). Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response. Radiotherapy and Oncology, 135, 1-12.
DOI Scopus33 WoS30 Europe PMC26
2019 Barabino, G., Frize, M., Ibrahim, F., Kaldoudi, E., Lhotska, L., Marcu, L., . . . Bezak, E. (2019). Solutions to Gender Balance in STEM Fields Through Support, Training, Education and Mentoring: Report of the International Women in Medical Physics and Biomedical Engineering Task Group. Science and Engineering Ethics, 26(1), 275-292.
DOI Scopus34 WoS28 Europe PMC13
2019 Marcu, L. G., Boyd, C., & Bezak, E. (2019). Feeding the data monster: data science in head and neck cancer for personalized therapy. Journal of the American college of radiology, 16(12), 1695-1701.
DOI Scopus9 WoS6 Europe PMC2
2019 Marcu, L., Boyd, C., & Bezak, E. (2019). Current issues regarding artificial intelligence in cancer and health care. Implications for medical physicists and biomedical engineers. Health and Technology, 9(4), 375-381.
DOI Scopus14 WoS13
2019 Forster, J. C., Marcu, L. G., & Bezak, E. (2019). Approaches to combat hypoxia in cancer therapy and the potential for in silico models in their evaluation. Physica Medica, 64, 145-156.
DOI Scopus23 WoS21 Europe PMC14
2019 Marcu, L. G., Forster, J. C., & Bezak, E. (2019). The Potential Role of Radiomics and Radiogenomics in Patient Stratification by Tumor Hypoxia Status. Journal of the American College of Radiology, 16(9), 1329-1337.
DOI Scopus15 WoS15 Europe PMC11
2019 Marcu, L. G., & Marcu, D. (2019). The role of hypofractionated radiotherapy in the management of head and neck cancer - a modelling approach. Journal of theoretical biology, 482(article no. 109998), 1-9.
DOI Scopus8 WoS7 Europe PMC5
2018 Marcu, L., Bezak, E., & Allen, B. (2018). Global comparison of targeted alpha vs targeted beta therapy for cancer: in vitro, in vivo and clinical trials. Critical Reviews in Oncology/Hematology, 123, 7-20.
DOI Scopus139 WoS113 Europe PMC87
2018 Reid, P., Wilson, P., Li, Y., Marcu, L., Staudacher, A., Brown, M., & Bezak, E. (2018). Experimental investigation of radiobiology in head and neck cancer cell lines as a function of HPV status, by MTT assay. Scientific Reports, 8(1), 7 pages.
DOI Scopus13 WoS12 Europe PMC8
2018 Marcu, L., Moghaddasi, L., & Bezak, E. (2018). Imaging of tumor characteristics and molecular pathways with PET: developments over the last decade toward personalized cancer therapy. International Journal of Radiation Oncology: Biology, Physics, 102(4), 1165-1182.
DOI Scopus40 WoS33 Europe PMC26
2018 Morias, S., Marcu, L., Short, M., Giles, E., & Bezak, E. (2018). Do SABR-related toxicities for lung cancer depend on treatment delivery?. Critical Reviews in Oncology/Hematology, 129, 67-78.
DOI Scopus1 WoS1 Europe PMC1
2018 Marcu, L., Reid, P., & Bezak, E. (2018). The promise of novel biomarkers for head and neck cancer from an imaging perspective. International Journal of Molecular Sciences, 19(9), 15 pages.
DOI Scopus23 WoS23 Europe PMC19
2018 Huynh, M., Marcu, L. G., Giles, E., Short, M., Matthews, D., & Bezak, E. (2018). Current status of proton therapy outcome for paediatric cancers of the central nervous system – Analysis of the published literature. Cancer Treatment Reviews, 70, 272-288.
DOI Scopus22 WoS17 Europe PMC13
2018 Morias, S., Marcu, L. G., Short, M., Giles, E., Potter, A., Shepherd, J., . . . Bezak, E. (2018). Treatment-Related Adverse Effects in Lung Cancer Patients after Stereotactic Ablative Radiation Therapy. Journal of Oncology, 2018(6483626), 16 pages.
DOI Scopus19 WoS17 Europe PMC11
2017 Marcu, L. G. (2017). Photons - Radiobiological issues related to the risk of second malignancies. Physica Medica, 42, 1-8.
DOI Scopus25 WoS22 Europe PMC21
2017 Bezak, E., Takam, R., Yeoh, E., & Marcu, L. (2017). The risk of second primary cancers due to peripheral photon and neutron doses received during prostate cancer external beam radiation therapy. Physica Medica, 42, 253-258.
DOI Scopus20 WoS16 Europe PMC15
2017 So, B., Marcu, L. G., Olver, I., Gowda, R., & Bezak, E. (2017). Cocktail without hangover: in search for the optimal chemotherapy in the combined management of non-operable esophageal carcinomas. Acta Oncologica, 56(7), 899-908.
DOI Scopus3 WoS3 Europe PMC3
2017 So, B., Marcu, L., Olver, I., Gowda, R., & Bezak, E. (2017). Oesophageal cancer: Which treatment is the easiest to swallow? A review of combined modality treatments for resectable carcinomas. Critical Reviews in Oncology/Hematology, 113, 135-150.
DOI Scopus10 WoS8 Europe PMC5
2017 Reid, P., Wilson, P., Li, Y., Marcu, L., & Bezak, E. (2017). Current understanding of cancer stem cells: review of their radiobiology and role in head and neck cancers. Head and Neck, 39(9), 1920-1932.
DOI Scopus48 WoS42 Europe PMC31
2017 Marcu, L. G., & Marcu, D. (2017). The effect of targeted therapy on recruited cancer stem cells in a head and neck carcinoma model. Cell proliferation, 50(6, article no. e12380), 1-9.
DOI Scopus4 WoS5 Europe PMC4
2017 Reid, P., Wilson, P., Li, Y., Marcu, L. G., Staudacher, A. H., Brown, M. P., & Bezak, E. (2017). In vitro investigation of head and neck cancer stem cell proportions and their changes following X-ray irradiation as a function of HPV status. PLoS ONE, 12(10), 16 pages.
DOI Scopus20 WoS18 Europe PMC17
2016 Chirla, R., & Marcu, L. G. (2016). PET-based quantification of statistical properties of hypoxic tumor subvolumes in head and neck cancer. Physica Medica, 32(1), 23-35.
DOI Scopus20 WoS21 Europe PMC19
2016 Marcu, L., Marcu, D., & Filip, S. (2016). In silico study of the impact of cancer stem cell dynamics and radiobiological hypoxia on tumour response to hyperfractionated radiotherapy. Cell Proliferation, 49(3), 304-314.
DOI Scopus13 WoS12 Europe PMC8
2016 Marcu, L. G. (2016). Future treatment directions for HPV-associated head and neck cancer based on radiobiological rationale and current clinical evidence. Critical Reviews in Oncology/Hematology, 103, 27-36.
DOI Scopus21 WoS19 Europe PMC18
2016 Santos, A., Marcu, L., Wong, C., & Bezak, E. (2016). Risk estimation of second primary cancers after breast radiotherapy. Acta Oncologica, 55(11), 1331-1337.
DOI Scopus31 WoS27 Europe PMC24
2016 Marcu, L. G., & Marcu, D. (2016). In silico modelling of a cancer stem cell-targeting agent and its effects on tumour control during radiotherapy. Scientific reports, 6(1), 1-8.
DOI Scopus17 WoS14 Europe PMC9
2015 Bezak, E., Takam, R., & Marcu, L. (2015). Peripheral photon and neutron doses from prostate cancer external beam irradiation. Radiation Protection Dosimetry, 167(4), 591-601.
DOI Scopus11 WoS7 Europe PMC2
2015 Jennings, M., Marcu, L., & Bezak, E. (2015). PET-specific parameters and radiotracers in theoretical tumour modelling. Computational and Mathematical Methods in Medicine, 2015(415923), 415923-1-415923-11.
DOI Scopus10 WoS10 Europe PMC8
2015 Marcu, L. G., Bezak, E., Toma-Dasu, I., & Dasu, A. (2015). Predictive models of tumour response to treatment using functional imaging techniques. Computational and Mathematical Methods in Medicine, 2015, 571371-1-571371-2.
DOI Scopus2 WoS1 Europe PMC2
2015 Marcu, L. G. (2015). The first Rs of radiotherapy: or standing on the shoulders of giants. Australasian physical and engineering sciences in medicine, 38(4), 531-541.
DOI Scopus4 WoS3 Europe PMC3
2014 Marcu, L., Santos, A., & Bezak, E. (2014). Risk of second primary cancer after breast cancer treatment. European Journal of Cancer Care, 23(1), 51-64.
DOI Scopus34 WoS32 Europe PMC26
2014 Marcu, L., Harriss-Phillips, W., & Filip, S. (2014). Hypoxia in head and neck cancer in theory and practice: a PET-based imaging approach. Computational and Mathematical Methods in Medicine, 2014, 624642-1-624642-13.
DOI Scopus8 WoS8 Europe PMC9
2014 Marcu, L. (2014). Tumour repopulation and the role of abortive division in squamous cell carcinomas during chemotherapy. Cell Proliferation, 47(4), 318-325.
DOI Scopus8 WoS8 Europe PMC8
2014 Sjostedt, S., Bezak, E., & Marcu, L. (2014). Experimental investigation of the cell survival in dose cold spot. Acta Oncologica, 53(1), 16-24.
DOI Scopus1 WoS1 Europe PMC2
2013 Marcu, L. (2013). Improving therapeutic ratio In head and neck cancer with adjuvant and cisplatin-based treatments. BioMed Research International, 2013, 1-9.
DOI Scopus10 WoS8 Europe PMC6
2013 Rutten, T., Lawson, J., & Marcu, L. (2013). Treatment technique evolution and dosimetry trends over seven years of low dose rate prostate brachytherapy at an Australian institution. Physica Medica, 29(6), 662-669.
DOI Scopus6 WoS6 Europe PMC5
2013 Marcu, L., & Lawson, J. (2013). Technical and dosimetric aspects of iodine-125 seed reimplantation in suboptimal prostate implants. British Journal of Radiology, 86(1026), 130058-1-130058-10.
DOI Scopus4 WoS3 Europe PMC2
2013 Marcu, L., & Gowda, R. (2013). Comparison of 3 different postimplant dosimetry methods following permanent ¹²⁵I prostate seed brachytherapy. Medical Dosimetry, 38(3), 309-314.
DOI Scopus7 WoS7 Europe PMC5
2013 Allen, B., Bezak, E., & Marcu, L. (2013). Quo vadis radiotherapy? Technological advances and the rising problems in cancer management. BioMed Research International, 2013(749203), 1-9.
DOI Scopus12 WoS9 Europe PMC9
2012 Moorrees, J., Lawson, J., & Marcu, L. (2012). Assessment of I-125 seed implant accuracy when using the live-planning technique for low dose rate prostate brachytherapy. Radiation Oncology, 7(196), 1-9.
DOI Scopus3 WoS3 Europe PMC1
2012 Moghaddasi, F., Bezak, E., & Marcu, L. (2012). Current challenges in clinical target volume definition: tumour margins and microscopic extensions. Acta Oncologica, 51(8), 984-995.
DOI Scopus26 WoS23 Europe PMC22
2012 Marcu, L., & Bezak, E. (2012). Influence of stem-cell cycle time on accelerated re-population during radiotherapy in head and neck cancer. Cell Proliferation, 45(5), 404-412.
DOI Scopus5 WoS5 Europe PMC5
2012 Marcu, L., & Harriss-Phillips, W. (2012). In silico modelling of treatment-induced tumour cell kill: Developments and advances. Computational and Mathematical Methods in Medicine, 2012, 1-16.
DOI Scopus24 WoS21 Europe PMC19
2012 Moghaddasi, F., Bezak, E., & Marcu, L. (2012). In silico modelling of tumour margin diffusion and infiltration: Review of current status. Computational and Mathematical Methods in Medicine, 2012(672895), 1-12.
DOI Scopus10 WoS8 Europe PMC7
2012 Penfold, S., Marcu, L., Lawson, J., & Asp, J. (2012). Evaluation of physician eye lens doses during permanent seed implant brachytherapy for prostate cancer. Journal of Radiological Protection, 32(3), 339-347.
DOI Scopus3 WoS3 Europe PMC1
2012 Marcu, L., Lawson, J., Rutten, T., & Gowda, R. (2012). Quality indicators and technique for analyzing permanent I-125 prostate seed implants: Seven years postimplant dosimetry evaluation. Medical Physics, 39(7), 4123-4131.
DOI Scopus7 WoS6 Europe PMC6
2012 Takam, R., Bezak, E., Liu, G., & Marcu, L. (2012). The use of enriched ⁶Li and ⁷Li Lif:Mg,Cu,P glass-rod thermoluminescent dosemeters for linear accelerator out-of-field radiation dose measurements. Radiation Protection Dosimetry, 150(1), 22-33.
DOI Scopus10 WoS11 Europe PMC4
2012 Marcu, L., Bezak, E., & Filip, S. (2012). The role of PET imaging in overcoming radiobiological challenges in the treatment of advanced head and neck cancer. Cancer Treatment Reviews, 38(3), 185-193.
DOI Scopus6 WoS5 Europe PMC4
2012 Marcu, L., & Bezak, E. (2012). Neoadjuvant cisplatin for head and neck cancer: Simulation of a novel schedule for improved therapeutic ratio. Journal of Theoretical Biology, 297, 41-47.
DOI Scopus7 WoS6 Europe PMC5
2012 Bezak, E., Marcu, L., & Penfold, S. (2012). Computational and mathematical modeling of tumor kinetics and response to radiation and chemotherapy. Computational and Mathematical Methods in Medicine, 2012, 702675-1-702675-2.
DOI
2012 Marcu, L. G., Lawson, J. M., Rutten, T., & Gowda, R. (2012). Quality indicators and technique for analyzing permanent I-125 prostate seed implants: Seven years postimplant dosimetry evaluation.. Medical physics, 39(7Part1), 4123-4131.
DOI
2011 Takam, R., Bezak, E., Marcu, L., & Yeoh, E. (2011). Out-of-field neutron and leakage photon exposures and the associated risk of second cancers in high-energy photon radiotherapy: Current status. Radiation Research, 176(4), 508-520.
DOI Scopus47 WoS46 Europe PMC31
2010 Marcu, L., & Yeoh, E. (2010). The emerging role of predictive assays in the management of head and neck cancer. Austral-Asian Journal of Cancer, 9(2), 71-77.
2010 Marcu, L., & Bezak, E. (2010). Modelling of tumour repopulation after chemotherapy. Australasian Physical and Engineering Sciences in Medicine, 33(3), 265-270.
DOI Scopus12 WoS12 Europe PMC12
2010 Takam, R., Bezak, E., Yeoh, E., & Marcu, L. (2010). Assessment of normal tissue complications following prostate cancer irradiation: Comparison of radiation treatment modalities using NTCP models. Medical Physics, 37(9), 5126-5137.
DOI Scopus27 WoS26 Europe PMC22
2010 Marcu, L., & Bezak, E. (2010). Stochastic modelling of the role of cisplatin in altered fractionation schedules for head and neck cancer. Physica Medica, 26(4), 177-183.
DOI Scopus4 WoS3 Europe PMC4
2010 Marcu, L. (2010). Altered fractionation in radiotherapy: From radiobiological rationale to therapeutic gain. Cancer Treatment Reviews, 36(8), 606-614.
DOI Scopus37 WoS32 Europe PMC29
2009 Marcu, L., & Bezak, E. (2009). Radiobiological modeling of interplay between accelerated repopulation and altered fractionation schedules in head and neck cancer. Journal of Medical Physics, 34(4), 206-211.
DOI Scopus19 WoS17 Europe PMC13
2009 Marcu, L., & Yeoh, E. (2009). A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment. Journal of Cancer Research and Clinical Oncology, 135(10), 1303-1314.
DOI Scopus62 WoS59 Europe PMC48
2009 Marcu, L. (2009). The role of amifostine in the treatment of head and neck cancer with cisplatin-radiotherapy. European Journal of Cancer Care, 18(2), 116-123.
DOI Scopus13 WoS13 Europe PMC11
2008 Harriss-Phillips, W., Bezak, E., Yeoh, E., & Marcu, L. (2008). Efficient Monte Carlo modelling of individual tumour cell propagation for hypoxic head and neck cancer. Physics in Medicine and Biology, 53(17), 4489-4507.
DOI Scopus17 WoS16 Europe PMC11
2006 Marcu, L., & Olver, I. (2006). Tirapazamine: from bench to clinical trials. Current Clinical Pharmacology, 1(1), 71-79.
DOI Scopus111 WoS105 Europe PMC79
2006 Marcu, L., & Quach, K. (2006). The role of post-implant dosimetry in the quality assessment of prostate implants. The RAH experience. Australasian Physical and Engineering Sciences in Medicine, 29(4), 310-314.
DOI Scopus10 Europe PMC8
2006 Marcu, L., Bezak, E., & Olver, I. (2006). Scheduling cisplatin and radiotherapy in the treatment of squamous cell carcinomas of the head and neck: a modelling approach. Physics in Medicine and Biology, 51(15), 3625-3639.
DOI Scopus31 WoS28 Europe PMC26
2005 Marcu, L., Bezak, E., Olver, I., & Van Doorn, T. (2005). Tumour resistance to cisplatin: a modelling approach. Physics in Medicine and Biology, 50(1), 93-102.
DOI Scopus21 WoS20 Europe PMC15
2004 Marcu, L., Van Doorn, T., & Olver, I. (2004). Modelling of post-irradiation accelerated repopulation in squamous cell carcinomas. Physics in Medicine and Biology, 49(16), 3767-3779.
DOI Scopus36 WoS34 Europe PMC31
2004 Marcu, L., Lyons, A., Bezak, E., & Van Doorn, T. (2004). The onset of tumour repopulation after radiotherapy in theoretical and in vitro models. Austral-Asian Journal of Cancer, 3(3), 167-171.
2003 Marcu, L., Van Doorn, T., & Olver, I. (2003). Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer - a review of their cooperation. Acta Oncologica, 42(4), 315-325.
DOI Scopus61 WoS54 Europe PMC48
2002 Marcu, L., Van Doorn, T., Zavgorodni, S., & Olver, I. (2002). Growth of a virtual tumour using probabilistic methods of cell generation. Australasian Physical and Engineering Sciences in Medicine, 25(4), 155-161.
DOI Scopus22 Europe PMC20

Year Citation
2025 Bezak, E., Marcu, L., & da Silva, A. M. M. (2025). Advocacy and Science Diplomacy in Support of International Collaborations. In Global Medical Physics A Guide for International Collaboration (pp. 132-145). CRC Press.
DOI
2015 Marcu, L. G. (Ed.) (2015). Contemporary Issues in Head and Neck Cancer Management. In . InTech.
DOI
2012 Marcu, L. G., & Yeoh, E. (2012). Tumour Repopulation During Treatment for Head and Neck Cancer: Clinical Evidence, Mechanisms and Minimizing Strategies. In L. G. Marcu, & E. Yeoh (Eds.), Tumour Repopulation During Treatment for Head and Neck Cancer: Clinical Evidence, Mechanisms and Minimizing Strategies (pp. 253-272).

Year Citation
2023 Costin, I. C., Costin, I., & Marcu, L. G. (2023). The impact of breast board and body mass index on setup errors during breast cancer radiotherapy. In RADIOTHERAPY AND ONCOLOGY Vol. 182 (pp. S1834-S1835). AUSTRIA, Vienna: ELSEVIER IRELAND LTD.
2023 Abbott, N. L., Appelt, A., Chauvie, S., DeJean, C., Gasnier, A., Koutsouveli, E., . . . Hansen, C. R. (2023). The role of medical physicists in clinical trials across Europe. In RADIOTHERAPY AND ONCOLOGY Vol. 182 (pp. S8-S9). AUSTRIA, Vienna: ELSEVIER IRELAND LTD.
2020 Tomse, R., Rahota, D., Miere, A. M., Marcut, C., & Marcu, L. G. (2020). Radioactivity monitoring in foodstuff and drinking water in Bihor County, Romania. In M. Lungu, A. Popescu, & C. Sporea (Eds.), AIP Conference Proceedings Vol. 2218 (pp. 1-6). US: American Institute of Physics.
DOI Scopus1 WoS1
2019 Marcu, L. G., & Marcu, D. (2019). Gender balance in medical physics-lost in transition?. In L. Lhotska (Ed.), Proceedings of the World Congress on Medical Physics and Biomedical Engineering Vol. 68 (pp. 737-740). Singapore: Springer.
DOI Scopus1
2019 Dinu, A., Flonta, T., & Marcu, L. (2019). The impact of breast irradiation using thermoplastic mask on quality of life. In RADIOTHERAPY AND ONCOLOGY Vol. 133 (pp. S1215-S1216). ITALY, Milan: ELSEVIER IRELAND LTD.
DOI
2017 Marcu, L. G., & Marcu, D. (2017). In silico modelling of radiation effects towards personalised treatment in radiotherapy. In D. Vizman, & A. Popescu (Eds.), AIP Conference Proceedings Vol. 1916 (pp. 1-7). US: AIP Publishing.
DOI Scopus2 WoS2
2017 Marcu, L. G., & Marcu, D. (2017). The interplay between all-trans-retinoic acid and radiotherapy in inducing cancer stem cell arrest. In RADIOTHERAPY AND ONCOLOGY Vol. 122 (pp. 26). Barcelona, SPAIN: ELSEVIER IRELAND LTD.
DOI
2017 Dinu, A., Flonta, T., Virag, V., & Marcu, L. (2017). Breast irradiation using personalised thermoplastic mask for immobilisation: Pros and cons. In EUROPEAN JOURNAL OF CANCER Vol. 72 (pp. S28). NETHERLANDS, Amsterdam: ELSEVIER SCI LTD.
DOI
2016 Marcu, L. G., & Marcu, D. (2016). Hyper- versus hypofractionated radiotherapy in a radioresistant head and neck cancer model. In RADIOTHERAPY AND ONCOLOGY Vol. 119 (pp. S801). ELSEVIER IRELAND LTD.
DOI
2016 Marcu, L. G., & Marcu, D. (2016). Modeling the effect of symmetrical division of cancer stem cells on tumour response to radiation. In RADIOTHERAPY AND ONCOLOGY Vol. 118 (pp. S70). ELSEVIER IRELAND LTD.
2014 Marcu, L. G. (2014). The effect of abortive division as a repopulation mechanism on head and neck cancer radiotherapy. In RADIOTHERAPY AND ONCOLOGY Vol. 111 (pp. S301). ELSEVIER IRELAND LTD.
2007 Bezak, E., Takam, R., Yeoh, E., & Marcu, L. (2007). Risk of rectal second cancer following prostate radiotherapy. In RADIOTHERAPY AND ONCOLOGY Vol. 84 (pp. S68-S69). Barcelona, SPAIN: ELSEVIER IRELAND LTD.
2006 Marcu, L., & Bezak, E. (2006). Radiobiological modelling of the interplay between accelerated repopulation and altered fractionation schedules in head and neck cancers. In RADIOTHERAPY AND ONCOLOGY Vol. 78 (pp. S65). Lugano, SWITZERLAND: ELSEVIER IRELAND LTD.
DOI
2006 Bezak, E., & Marcu, L. (2006). Patient dose due to electronic portal imaging. In RADIOTHERAPY AND ONCOLOGY Vol. 78 (pp. S58-S59). Lugano, SWITZERLAND: ELSEVIER IRELAND LTD.
DOI

Year Citation
2019 De Courcy, L., Bezak, E., & Marcu, L. (2019). GENDER-DEPENDANT RADIATION THERAPY; THE NEXT STEP IN PERSONALISED MEDICINE?. Poster session presented at the meeting of IRISH JOURNAL OF MEDICAL SCIENCE. SPRINGER LONDON LTD.

Date Role Research Topic Program Degree Type Student Load Student Name
2017 - 2021 Co-Supervisor Comparative radiobiology of HPV positive and HPV negative head and neck cancers Doctor of Philosophy Doctorate Full Time Mr Paul Reid

Connect With Me

External Profiles

Other Links